Study Purpose:Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.
The major goal of the project is to develop human iPS cells from various types of cell cultures or lines from existing collections. The IPS cells will be developed for modeling diseases, for developing the technology that may eventually allow the use of IPS cells for transplantation therapy, and for basic research.
Amyotrophic Lateral Sclerosis
Type of Intervention:
Study Chair(s)/Principal Investigator(s):
Benjamin E Reubinoff, MD PhD, Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem
Coordinating Center Contact Information
Full Study Summary:
We will induce the differentiation of the iPS cells towards specific cell lineages and the progeny can be used to study the pathogenesis of diseases. They will be used for developing new therapeutic approaches and for high throughput screening of factors for potential toxic or therapeutic effects.
All samples will be non-identified.
Hadassah Medical Organization
Estimated Study Start Date:
11 / 01 / 2008
Estimated Study Completion Date:
12 / 01 / 2025
Posting Last Modified Date:
08 / 16 / 2022
Date Study Added to neals.org:
12 / 03 / 2008
- Male and Female
- Below the official age of consent
Hadassah Medical Organization - Ein Kerem Campus | Recruiting
Hadassah Ein Kerem | Recruiting